GLP-1 obesity drugs set to become access battleground in lower-income countries
Published 2 d ago1 sourceEvidence: Reported
Experts flag that GLP-1 obesity medications suppress appetite and food intake, potentially causing deficiencies in protein, fiber, vitamins, and minerals. The claim is an expert warning rather than a new clinical finding, and the magnitude of risk remains uncertain. This matters as GLP-1 use expands, adding a public-health and clinical-management dimension to the drug class's rapid adoption.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 3 h ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported